Top Biotech Companies in Singapore (112)
Systemic Bio is a 3D Systems company based in Houston, Texas, focused on the development of vascularized organ models made out of hydrogels and human cells to be used for drug discovery and development.
Mobcoder is a global technology company specializing in AI development and innovative solutions. Since 2014, we've launched over 300 apps, empowering businesses across various industries and locations.
Nuevocor is a new biotech start-up in Singapore striving to develop gene therapies for genetic cardiomyopathies. It will leverage a deep understanding of cardiac cell biology, as well as a technology platform encompassing novel gene therapy vectors and proteomics-based target discovery
Kemin Industries is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human health, food safety and protection of the global food supply chain. Kemin ingredients offer solutions across various industries including animal health, nutraceuticals,...
Align Technology is a global medical device company focused on digital orthodontics and restorative dentistry. It designs, manufactures, and sells the Invisalign clear-aligner system, iTero intraoral scanners, and exocad CAD/CAM software. Its platform combines 3D modeling, biomechanical shape engineering, mass customization, and 3D printing to support doctors, dental practices, laboratories, and patients with integrated digital treatment workflows.
Grifols is a global healthcare company that develops, produces and markets plasma-derived medicines, other biopharmaceuticals, and solutions in transfusion medicine. Its work spans plasma, diagnostics, and life sciences, and it develops and markets medicines, solutions, and services in more than 110 countries. Grifols says its mission is to improve people's health and well-being, with patients, donors, and society at the...
Grifols's Top Stability & Growth Strengths
Strong Revenue Growth: Grifols grew revenue to €2.040 billion in Q3 2026 (up 8.4% at constant currency) and €5.614 billion for the first nine months (up 4.6%), with Biopharma and immunoglobulins as the main engines. This trajectory follows full-year 2025 revenue growth and continued demand for plasma-derived medicines.
Profitability: Grifols increased earnings, reporting Q3 2026 net profit of €162 million (up 27.9% year over year) and €390 million year to date (up 28.4%). Profit gains have been supported by a stronger Biopharma mix, specialty proteins, and operational improvements at Biotest.
Healthy Cash Flow: Grifols lifted free cash flow pre-M&A to €298 million for the first nine months of 2026 and reported €2.14 billion in liquidity with net leverage reduced to 3.98x. These improvements provide financial flexibility as the company expands plasma collection, including the Grifols Egypt initiative.
Founded in 2019, Virtue Diagnostics is an in vitro diagnostic provider committed to platform innovation in emerging markets. We have built a management team with decades of experience in the in vitro diagnostic industry and a global vision, coupled with robust R&D, operation and commercialization capabilities. We set up our industrialization bases in China, Brazil and Indonesia, and R&D centers...
Cytek Biosciences develops cell-analysis solutions for biomedical researchers, pharmaceutical companies, contract research organizations, and academic institutions. Its platform centers on patented Full Spectrum Profiling technology and includes flow cytometry instruments and cell sorters, imaging systems, reagents, software, and services. By analyzing the full spectrum of fluorescent signals, these tools enable sensitive, high-content cellular analysis and help scientists obtain deeper biological...
Novotech is a global full‑service clinical research organization (CRO) and scientific advisory partner that provides clinical trial execution, regulatory, laboratory and consulting services to biotech and small- to mid‑sized pharmaceutical companies. Operating across the Asia‑Pacific region and beyond with multiple offices and strategic site partnerships, Novotech helps sponsors accelerate development and access diverse patient populations for global drug development.
Rakuten Medical, Inc. is a global clinical stage biotechnology company developing and commercializing precision, cell-targeting investigational therapies on its AlluminoxTM platform, which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Outside of Japan, Alluminox therapies have not yet been approved as safe or effective by any regulatory authority. The company’s first drug...
Suzano S.A. is a global leader in eucalyptus pulp production and one of the largest producers of paper and packaging in Latin America. Operating as a bioeconomy company, it develops sustainable and innovative products from renewable raw materials, reaching over two billion people in more than 100 countries globally. Its extensive portfolio includes pulp, paperboard, and tissue paper, driven by...
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies,...
Merck's Top Stability & Growth Strengths
Strong Revenue Growth: Merck is expanding revenue with Q3 2026 sales of $18.1 billion, up about 5% year over year, and trailing twelve‑month revenue of $67.38 billion, up 4.89%. Management also raised the midpoint of its 2026 sales outlook to $66.8–$67.3 billion.
Strong Market Position & Advantage: Merck holds a leading market position in oncology and vaccines, anchored by Keytruda, which generated more than $31 billion in 2025 and was the world’s best‑selling pharmaceutical product. Scale across vaccines and animal health further reinforces Merck’s competitive position.
Product Line Growth: Merck’s newer products are expanding rapidly, with Q3 2026 results showing Winrevair up 93% to $694 million and Welireg up 56% to $307 million alongside contributions from Keytruda Qlex and Ohtuvayre. Animal Health also grew to $1.7 billion in the quarter, signaling breadth in product momentum.
Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, "Novotech" and "PPC". Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services.
STEMCELL Technologies is a Canadian biotechnology company that helps power leading-edge life science research around the world. Driven by our love of science and passion for quality, we are Scientists Helping Scientists—standing by our customers to provide the outstanding products, technical support, and training they need to advance their research. Scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular...
Tricon Energy is a global leader in the trade and distribution of industrial chemicals, fuels, plastic intermediates, and fertilizers. Founded in 1996, the company's mission is to sustainably and efficiently connect the world with essential goods by providing superior logistics, risk management, financing, and market intelligence services to its clients and suppliers worldwide.
For 85 years, PerkinElmer has pushed the boundaries of science from food to health to the environment. We’ve always pursued science with a clear purpose – to help our customers achieve theirs. Our expert team brings technology and intangibles, like creativity, empathy, diligence, and a spirit of collaboration, in equal measure, to fulfill our customers’ desire to work better, innovate...
PerkinElmer's Top Stability & Growth Strengths
Strong Market Position & Advantage: Colleagues are often seen as operating from a top-tier competitive position in applied, food, and environmental analytical markets, including a significant presence in food testing and leadership in multivendor lab services via OneSource. The large global installed base and asset footprint are portrayed as reinforcing defensibility and ongoing demand for services and support.
Innovation-Driven Growth: Colleagues are often seen as sustaining relevance through ongoing product launches and upgrades such as digital PCR systems, updated LIMS software, and new analytical platforms aimed at emerging needs like PFAS detection and battery applications. The continued cadence of new instruments and workflow solutions is positioned as a key growth lever alongside services and consumables.
Investor Backing & Capital Strength: Colleagues are often seen as supported by private-equity ownership under New Mountain Capital and described with a substantial valuation, suggesting access to capital and an explicit mandate to scale. Recent acquisitions (e.g., Covaris and Project Farma) are framed as capability-building moves consistent with a funded expansion strategy.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
X-ZELL is an award-winning medical technology start-up specialising in next-generation cytology. Cytology – or cytopathology – is the science of diagnosing diseases by examining single atypical cells or cell clusters. X-ZELL has developed a plug-and-play solution for the detection, visualization and digitization of these phenomena in minimally invasive body liquids. Slotting seamlessly into clinical routine, it does not require complex...
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt...
Oxford Nanopore Technologies's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show a meaningful step‑up in 2025 revenue with double‑digit year‑over‑year growth and guidance pointing to continued double‑digit expansion into 2026. Feedback suggests performance was slightly ahead of prior guidance and supported by broad‑based demand across regions and customer segments.
Strong Market Position & Advantage: ONT is described as a clear leader in nanopore sequencing and a co‑leader in long‑reads, differentiated by portability, real‑time analysis, ultra‑long reads, and native DNA/RNA methylation detection. Flagship datasets and assemblies reinforce this positioning.
Market Expansion: Updates highlight accelerating adoption beyond academia into clinical, applied industrial and biopharma use cases, alongside growing high‑throughput deployments on PromethION. Feedback suggests growth was evident across major geographies and end‑markets with notable momentum in regulated and applied settings.
Heilind Electronics is a global electronic components distributor specializing in interconnect, electromechanical, and sensor solutions. Founded in 1974, the company is recognized as a leading distributor of connectors and terminal blocks, particularly in North America. They provide access to an extensive inventory from over 170 world-class manufacturers, offering products such as relays, switches, and thermal management solutions with a customer-first...
































